Pediatrix Medical Gross Margin 2010-2023 | MD
Current and historical gross margin for Pediatrix Medical (MD) over the last 10 years. The current gross profit margin for Pediatrix Medical as of December 31, 2023 is %.
| Pediatrix Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $2.00B | $0.42B | 21.10% |
| 2023-09-30 | $2.01B | $0.44B | 21.66% |
| 2023-06-30 | $2.00B | $0.44B | 22.24% |
| 2023-03-31 | $1.98B | $0.45B | 22.92% |
| 2022-12-31 | $1.97B | $0.47B | 23.68% |
| 2022-09-30 | $1.96B | $0.49B | 24.99% |
| 2022-06-30 | $1.96B | $0.51B | 26.12% |
| 2022-03-31 | $1.95B | $0.52B | 26.66% |
| 2021-12-31 | $1.91B | $0.51B | 26.88% |
| 2021-09-30 | $1.83B | $0.48B | 26.45% |
| 2021-06-30 | $1.80B | $0.47B | 26.36% |
| 2021-03-31 | $1.74B | $0.45B | 26.09% |
| 2020-12-31 | $1.73B | $0.45B | 25.89% |
| 2020-09-30 | $1.78B | $0.48B | 26.80% |
| 2020-06-30 | $1.77B | $0.48B | 27.06% |
| 2020-03-31 | $1.92B | $0.54B | 28.29% |
| 2019-12-31 | $2.33B | $0.65B | 27.73% |
| 2019-09-30 | $1.02B | $0.33B | 32.03% |
| 2019-06-30 | $1.42B | $0.42B | 29.55% |
| 2019-03-31 | $1.72B | $0.49B | 28.34% |
| 2018-12-31 | $1.72B | $0.51B | 29.29% |
| 2018-09-30 | $3.27B | $0.87B | 26.52% |
| 2018-06-30 | $3.29B | $0.90B | 27.30% |
| 2018-03-31 | $3.27B | $0.91B | 27.70% |
| 2017-12-31 | $3.25B | $0.92B | 28.27% |
| 2017-09-30 | $3.38B | $1.00B | 29.71% |
| 2017-06-30 | $3.34B | $1.03B | 30.74% |
| 2017-03-31 | $3.27B | $1.04B | 31.68% |
| 2016-12-31 | $3.18B | $1.03B | 32.47% |
| 2016-09-30 | $3.10B | $1.02B | 33.09% |
| 2016-06-30 | $2.99B | $1.00B | 33.36% |
| 2016-03-31 | $2.89B | $0.97B | 33.38% |
| 2015-12-31 | $2.78B | $0.93B | 33.38% |
| 2015-09-30 | $2.69B | $0.90B | 33.32% |
| 2015-06-30 | $2.59B | $0.86B | 33.08% |
| 2015-03-31 | $2.51B | $0.83B | 33.03% |
| 2014-12-31 | $2.44B | $0.81B | 33.07% |
| 2014-09-30 | $2.36B | $0.77B | 32.85% |
| 2014-06-30 | $2.28B | $0.75B | 32.92% |
| 2014-03-31 | $2.22B | $0.73B | 32.88% |
| 2013-12-31 | $2.15B | $0.71B | 32.96% |
| 2013-09-30 | $2.06B | $0.68B | 33.09% |
| 2013-06-30 | $1.98B | $0.66B | 33.20% |
| 2013-03-31 | $1.90B | $0.63B | 33.42% |
| 2012-12-31 | $1.82B | $0.61B | 33.74% |
| 2012-09-30 | $1.75B | $0.59B | 33.92% |
| 2012-06-30 | $1.69B | $0.58B | 34.10% |
| 2012-03-31 | $1.63B | $0.56B | 34.44% |
| 2011-12-31 | $1.59B | $0.55B | 34.70% |
| 2011-09-30 | $1.55B | $0.54B | 34.82% |
| 2011-06-30 | $1.49B | $0.52B | 34.87% |
| 2011-03-31 | $1.45B | $0.51B | 34.83% |
| 2010-12-31 | $1.40B | $0.49B | 34.83% |
| 2010-09-30 | $1.37B | $0.48B | 34.92% |
| 2010-06-30 | $1.35B | $0.47B | 35.07% |
| 2010-03-31 | $1.32B | $0.46B | 35.00% |
| 2009-12-31 | $1.29B | $0.45B | 35.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.748B | $1.995B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.431B | 15.74 |
| Cencora (COR) | United States | $47.828B | 19.09 |
| ICON (ICLR) | Ireland | $24.755B | 23.37 |
| DiDi Global (DIDIY) | China | $23.950B | 0.00 |
| Avantor (AVTR) | United States | $17.059B | 23.50 |
| Viatris (VTRS) | United States | $13.760B | 3.93 |
| CochLear (CHEOY) | $13.446B | 0.00 | |
| Revvity (RVTY) | United States | $12.611B | 21.95 |
| Medpace Holdings (MEDP) | United States | $12.076B | 39.73 |
| Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
| Natera (NTRA) | United States | $11.158B | 0.00 |
| Solventum (SOLV) | United States | $10.666B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.782B | 50.67 |
| Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
| Organon (OGN) | United States | $4.709B | 4.56 |
| Doximity (DOCS) | United States | $4.401B | 32.76 |
| PACS (PACS) | United States | $3.643B | 0.00 |
| Sotera Health (SHC) | United States | $3.204B | 15.72 |
| Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
| Progyny (PGNY) | United States | $3.124B | 52.42 |
| GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
| Life Times (LTH) | United States | $2.776B | 30.67 |
| Premier (PINC) | United States | $2.493B | 9.13 |
| Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
| Agilon Health (AGL) | United States | $2.109B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
| Embecta (EMBC) | United States | $0.599B | 3.95 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.86 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| LifeMD (LFMD) | United States | $0.437B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| Beauty Health (SKIN) | United States | $0.378B | 0.00 |
| MultiPlan (MPLN) | United States | $0.368B | 0.00 |
| DocGo (DCGO) | United States | $0.364B | 58.17 |
| ModivCare (MODV) | United States | $0.340B | 4.51 |
| Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
| Sharecare (SHCR) | United States | $0.266B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |